BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28534430)

  • 1. Variability in axillary lymph node delineation for breast cancer radiotherapy in presence of guidelines on a multi-institutional platform.
    Ciardo D; Argenone A; Boboc GI; Cucciarelli F; De Rose F; De Santis MC; Huscher A; Ippolito E; La Porta MR; Marino L; Meaglia I; Palumbo I; Rossi F; Alpi P; Bignardi M; Bonanni A; Cante D; Ceschia T; Fabbietti L; Lupattelli M; Mantero ED; Monaco A; Porcu P; Ravo V; Silipigni S; Tozzi A; Umina V; Zerini D; Bordonaro L; Capezzali G; Clerici E; Colangione SP; Dispinzieri M; Dognini J; Donadoni L; Falivene S; Fozza A; Grilli B; Guarnaccia R; Iannacone E; Lancellotta V; Prisco A; Ricotti R; Orecchia R; Jereczek-Fossa BA; Leonardi MC;
    Acta Oncol; 2017 Aug; 56(8):1081-1088. PubMed ID: 28534430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study.
    Leonardi MC; Pepa M; Gugliandolo SG; Luraschi R; Vigorito S; Rojas DP; La Porta MR; Cante D; Petrucci E; Marino L; Borzì G; Ippolito E; Marrocco M; Huscher A; Chieregato M; Argenone A; Iadanza L; De Rose F; Lobefalo F; Cucciarelli F; Valenti M; De Santis MC; Cavallo A; Rossi F; Russo S; Prisco A; Guernieri M; Guarnaccia R; Malatesta T; Meaglia I; Liotta M; Tabarelli de Fatis P; Palumbo I; Marcantonini M; Colangione SP; Mezzenga E; Falivene S; Mormile M; Ravo V; Arrichiello C; Fozza A; Barbero MP; Ivaldi GB; Catalano G; Vidali C; Aristei C; Giannitto C; Miglietta E; Ciabattoni A; Meattini I; Orecchia R; Cattani F; Jereczek-Fossa BA
    Br J Radiol; 2021 Jul; 94(1123):20201177. PubMed ID: 33882239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group.
    Nielsen MH; Berg M; Pedersen AN; Andersen K; Glavicic V; Jakobsen EH; Jensen I; Josipovic M; Lorenzen EL; Nielsen HM; Stenbygaard L; Thomsen MS; Vallentin S; Zimmermann S; Offersen BV;
    Acta Oncol; 2013 May; 52(4):703-10. PubMed ID: 23421926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dosimetric impact of axillary nodes contouring variability in breast cancer radiotherapy: An AIRO multi-institutional study.
    Leonardi MC; Pepa M; Luraschi R; Vigorito S; Dicuonzo S; Isaksson LJ; La Porta MR; Marino L; Ippolito E; Huscher A; Argenone A; De Rose F; Cucciarelli F; De Santis MC; Rossi F; Prisco A; Guarnaccia R; Tabarelli de Fatis P; Palumbo I; Colangione SP; Mormile M; Ravo V; Fozza A; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA;
    Radiother Oncol; 2022 Mar; 168():113-120. PubMed ID: 35033602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between current and historical breast cancer axillary lymph node irradiation based on arm position: implications for radiation oncologists.
    Saito AI; Vargas C; Morris CG; Lightsey J; Mendenhall NP
    Am J Clin Oncol; 2009 Aug; 32(4):381-6. PubMed ID: 19415030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of breast cancer axillary lymph node treatment plans based on 2-dimensional imaging: what we should know before interpreting 2-dimensional treatment-planning era studies.
    Saito AI; Lightsey J; Li JG; Copeland EM; Karasawa K; Vargas CE; Mendenhall NP
    Am J Clin Oncol; 2009 Aug; 32(4):387-95. PubMed ID: 19546802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized open label trial.
    Algara López M; Rodríguez García E; Beato Tortajada I; Martínez Arcelus FJ; Salinas Ramos J; Rodríguez Garrido JR; Sanz Latiesas X; Soler Rodríguez A; Juan Rijo G; Flaquer García A
    Radiat Oncol; 2020 Oct; 15(1):229. PubMed ID: 33008422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
    Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of an automatic delineation system for organs at risk and target lymph nodes volumes for patients treated for breast cancer].
    Arsène-Henry A; Xu HP; Robilliard M; El Amine W; Costa É; Kirova YM
    Cancer Radiother; 2018 May; 22(3):241-247. PubMed ID: 29628204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique.
    Goddu SM; Chaudhari S; Mamalui-Hunter M; Pechenaya OL; Pratt D; Mutic S; Zoberi I; Jeswani S; Powell SN; Low DA
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1243-51. PubMed ID: 19251096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional study.
    Leonardi MC; Pepa M; Zaffaroni M; Vincini MG; Luraschi R; Vigorito S; Morra A; Dicuonzo S; Mazzola GC; Gerardi MA; Zerella MA; Cante D; Petrucci E; Borzì G; Marrocco M; Chieregato M; Iadanza L; Lobefalo F; Valenti M; Cavallo A; Russo S; Guernieri M; Malatesta T; Meaglia I; Liotta M; Palumbo I; Marcantonini M; Mezzenga E; Falivene S; Arrichiello C; Barbero MP; Ivaldi GB; Catalano G; Vidali C; Giannitto C; Ciabattoni A; Meattini I; Aristei C; Orecchia R; Cattani F; Jereczek-Fossa BA
    Tumori; 2023 Dec; 109(6):570-575. PubMed ID: 37688419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified CT-based definition of the supraclavicular and infraclavicular nodal volumes in breast cancer.
    Atean I; Pointreau Y; Ouldamer L; Monghal C; Bougnoux A; Bera G; Barillot I
    Cancer Radiother; 2013 Feb; 17(1):39-43. PubMed ID: 23333457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of the depth of supraclavicular and axillary lymph nodes in patients with breast cancer: is a posterior axillary boost field necessary?
    Bentel GC; Marks LB; Hardenbergh PH; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):755-8. PubMed ID: 10837961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cranial organs at risk delineation: heterogenous practices in radiotherapy planning.
    Vogin G; Hettal L; Bartau C; Thariat J; Claeys MV; Peyraga G; Retif P; Schick U; Antoni D; Bodgal Z; Dhermain F; Feuvret L
    Radiat Oncol; 2021 Feb; 16(1):26. PubMed ID: 33541394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer regional radiation fields for supraclavicular and axillary lymph node treatment: is a posterior axillary boost field technique optimal?
    Wang X; Yu TK; Salehpour M; Zhang SX; Sun TL; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):86-91. PubMed ID: 18805650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of RTOG compliant patient CT-atlases for automated atlas based contouring of local regional breast and high-risk prostate cancers.
    Velker VM; Rodrigues GB; Dinniwell R; Hwee J; Louie AV
    Radiat Oncol; 2013 Jul; 8():188. PubMed ID: 23885662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Internal and external validation of an ESTRO delineation guideline - dependent automated segmentation tool for loco-regional radiation therapy of early breast cancer.
    Eldesoky AR; Yates ES; Nyeng TB; Thomsen MS; Nielsen HM; Poortmans P; Kirkove C; Krause M; Kamby C; Mjaaland I; Blix ES; Jensen I; Berg M; Lorenzen EL; Taheri-Kadkhoda Z; Offersen BV
    Radiother Oncol; 2016 Dec; 121(3):424-430. PubMed ID: 27697296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elective breast radiotherapy including level I and II lymph nodes: A planning study with the humeral head as planning risk volume.
    Surmann K; van der Leer J; Branje T; van der Sangen M; van Lieshout M; Hurkmans CW
    Radiat Oncol; 2017 Jan; 12(1):22. PubMed ID: 28100239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.